ÂÜÀòÂÒÂ×

Daniel Kallin is an accomplished scientist with extensive experience in biopharmaceutical research and development. Currently employed at BioNTech SE since May 2020, Daniel has held roles including Scientist, Associate Scientist, and Senior Research Associate, focusing on peptide purification and quality control. Prior experience at Neon Therapeutics involved similar responsibilities in peptide delivery for biological research. Daniel contributed to academic excellence through tutoring and teaching roles at the University of Massachusetts Amherst, where research on nanoparticles and antibiotic-resistant bacteria was undertaken. Internships at Alnylam Pharmaceuticals and Waters Corporation provided valuable analytical development and quality assurance experience. Daniel Kallin holds a Bachelor of Science in Chemical Engineering from the University of Massachusetts Amherst.